Study of women's knowledge of the role of androgens and their excess in women - research article
DOI:
https://doi.org/10.12775/JEHS.2023.17.01.010Keywords
hyperandrogenism, excess androgens, polycystic ovary syndrome, hirsutism, congenital adrenal hyperplasiaAbstract
Introduction: excess androgens is one of the most common endocrine disorder in women. The ovaries and/or adrenal glands are responsible for the excess of androgens. The most common cause is polycystic ovary syndrome.
The aim of the study: was to show the level of knowledge of the women surveyed about the role of androgens and to find out the degree of their awareness of androgen excess in women. Last but not least, it was important to find out which symptoms the respondents think are characteristic of androgen excess in women, whether they know the concept of hirsutism and what androgenetic alopecia looks like.
Material and method: wykorzystano ankietę własnego autorstwa. Przebadano 172 kobiety. Dokonano porównania odpowiedzi na pytania pomiędzy podgrupami. Oparto się na aktualnej literaturze medycznej oraz artykułach oryginalnych i badawczych znalezionych w PubMed.
Results: slightly more than half of those surveyed know that testosterone is produced by the ovaries and adrenal cortex. Only 35.5% of the women surveyed can name other hormones belonging to the androgens besides testosterone. 60.7% of women know the characteristic symptoms of hyperandrogenism. 51.7% know the term hirsutism and 32% correctly identify the most common cause.
Conclusions: given the prevalence of endocrine disorders in women, it is important to expand and disseminate information on the symptoms and causes of androgen excess in women, especially among women without medical education.
References
Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, Boivin J, Petraglia F, Wijeyeratne CN, Norman RJ, Dunaif A, Franks S, Wild RA, Dumesic D, Barnhart K. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012 Jan;97(1):28-38.e25. doi: 10.1016/j.fertnstert.2011.09.024. Epub 2011 Dec 6. PMID: 22153789.
Carmina E. Ovarian and adrenal hyperandrogenism. Ann N Y Acad Sci. 2006 Dec;1092:130-7. doi: 10.1196/annals.1365.011. PMID: 17308139.
Davison SL, Davis SR. Androgens in women. J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):363-6. doi: 10.1016/s0960-0760(03)00204-8. PMID: 12943723.
Lizneva D, Gavrilova-Jordan L, Walker W, Azziz R. Androgen excess: Investigations and management. Best Pract Res Clin Obstet Gynaecol. 2016 Nov;37:98-118. doi: 10.1016/j.bpobgyn.2016.05.003. Epub 2016 May 19. PMID: 27387253.
Dušková M, Kolátorová L, Stárka L. Androgens in women - critical evaluation of the methods for their determination in diagnostics of endocrine disorders. Physiol Res. 2018 Nov 28;67(Suppl 3):S379-S390. doi: 10.33549/physiolres.933964. PMID: 30484665.
Burger HG. Androgen production in women. Fertil Steril. 2002 Apr;77 Suppl 4:S3-5. doi: 10.1016/s0015-0282(02)02985-0. PMID: 12007895.
Hafsi W, Badri T. Hirsutism. 2022 Aug 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 29262139.
Aswini R, Jayapalan S. Modified Ferriman-Gallwey Score in Hirsutism and its Association with Metabolic Syndrome. Int J Trichology. 2017 Jan-Mar;9(1):7-13. doi: 10.4103/ijt.ijt_93_16. PMID: 28761258; PMCID: PMC5514800.
Lumezi BG, Berisha VL, Pupovci HL, Goçi A, Hajrushi AB. Grading of hirsutism based on the Ferriman-Gallwey scoring system in Kosovar women. Postepy Dermatol Alergol. 2018 Dec;35(6):631-635. doi: 10.5114/ada.2018.77615. Epub 2018 Nov 13. PMID: 30618534; PMCID: PMC6320479.
Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually scoring hirsutism. Hum Reprod Update. 2010 Jan-Feb;16(1):51-64. doi: 10.1093/humupd/dmp024. PMID: 19567450; PMCID: PMC2792145.
Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013 Dec 18;6:1-13. doi: 10.2147/CLEP.S37559. PMID: 24379699; PMCID: PMC3872139.
Martin KA, Anderson RR, Chang RJ, Ehrmann DA, Lobo RA, Murad MH, Pugeat MM, Rosenfield RL. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018 Apr 1;103(4):1233-1257. doi: 10.1210/jc.2018-00241. PMID: 29522147.
Cibula D, Hill M, Vohradnikova O, Kuzel D, Fanta M, Zivny J. The role of androgens in determining acne severity in adult women. Br J Dermatol. 2000 Aug;143(2):399-404. doi: 10.1046/j.1365-2133.2000.03669.x. PMID: 10951152.
Slayden SM, Moran C, Sams WM Jr, Boots LR, Azziz R. Hyperandrogenemia in patients presenting with acne. Fertil Steril. 2001 May;75(5):889-92. doi: 10.1016/s0015-0282(01)01701-0. PMID: 11334899.
Uysal G, Sahin Y, Unluhizarci K, Ferahbas A, Uludag SZ, Aygen E, Kelestimur F. Is acne a sign of androgen excess disorder or not? Eur J Obstet Gynecol Reprod Biol. 2017 Apr;211:21-25. doi: 10.1016/j.ejogrb.2017.01.054. Epub 2017 Jan 23. PMID: 28178574.
Lucky AW, McGuire J, Rosenfield RL, Lucky PA, Rich BH. Plasma androgens in women with acne vulgaris. J Invest Dermatol. 1983 Jul;81(1):70-4. doi: 10.1111/1523-1747.ep12539043. PMID: 6223099.
Vexiau P, Husson C, Chivot M, Brerault JL, Fiet J, Julien R, Villette JM, Hardy N, Cathelineau G. Androgen excess in women with acne alone compared with women with acne and/or hirsutism. J Invest Dermatol. 1990 Mar;94(3):279-83. doi: 10.1111/1523-1747.ep12874121. PMID: 2137846.
Auffret N, Claudel JP, Leccia MT, Poli F, Farhi D, Dréno B. AFAST - Adult Female Acne Scoring Tool: an easy-to-use tool for scoring acne in adult females. J Eur Acad Dermatol Venereol. 2016 May;30(5):824-8. doi: 10.1111/jdv.13518. Epub 2015 Dec 7. PMID: 26642798.
Dréno B, Poli F, Pawin H, Beylot C, Faure M, Chivot M, Auffret N, Moyse D, Ballanger F, Revuz J. Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe. J Eur Acad Dermatol Venereol. 2011 Jan;25(1):43-8. doi: 10.1111/j.1468-3083.2010.03685.x. PMID: 20456560.
Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA. A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women. J Drugs Dermatol. 2018 Apr 1;17(4):457-463. PMID: 29601622; PMCID: PMC6609098.
Olsen EA. Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss. J Am Acad Dermatol. 2003 Feb;48(2):253-62. doi: 10.1067/mjd.2003.81. PMID: 12582397.
Price VH. Androgenetic alopecia in women. J Investig Dermatol Symp Proc. 2003 Jun;8(1):24-7. doi: 10.1046/j.1523-1747.2003.12168.x. PMID: 12894991.
Rosenfield RL. Clinical practice. Hirsutism. N Engl J Med. 2005 Dec 15;353(24):2578-88. doi: 10.1056/NEJMcp033496. PMID: 16354894.
Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004 Feb;89(2):453-62. doi: 10.1210/jc.2003-031122. PMID: 14764747.
Schmidt TH, Shinkai K. Evidence-based approach to cutaneous hyperandrogenism in women. J Am Acad Dermatol. 2015 Oct;73(4):672-90. doi: 10.1016/j.jaad.2015.05.026. Epub 2015 Jun 30. PMID: 26138647.
Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab. 1999 Jun;84(6):1897-9. doi: 10.1210/jcem.84.6.5803. PMID: 10372683.
Matheson E, Bain J. Hirsutism in Women. Am Fam Physician. 2019 Aug 1;100(3):168-175. PMID: 31361105.
Chatziaggelou A, Sakkas EG, Votino R, Papagianni M, Mastorakos G. Assisted Reproduction in Congenital Adrenal Hyperplasia. Front Endocrinol (Lausanne). 2019 Oct 23;10:723. doi: 10.3389/fendo.2019.00723. PMID: 31708872; PMCID: PMC6819309.
El-Maouche D, Arlt W, Merke DP. Congenital adrenal hyperplasia. Lancet. 2017 Nov 11;390(10108):2194-2210. doi: 10.1016/S0140-6736(17)31431-9. Epub 2017 May 30. Erratum in: Lancet. 2017 Nov 11;390(10108):2142. PMID: 28576284.
Livadas S, Bothou C. Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach. Front Endocrinol (Lausanne). 2019 Jun 6;10:366. doi: 10.3389/fendo.2019.00366. PMID: 31244776; PMCID: PMC6563652.
Turcu AF, Auchus RJ. Adrenal steroidogenesis and congenital adrenal hyperplasia. Endocrinol Metab Clin North Am. 2015 Jun;44(2):275-96. doi: 10.1016/j.ecl.2015.02.002. PMID: 26038201; PMCID: PMC4506691.
Kirk LF Jr, Hash RB, Katner HP, Jones T. Cushing's disease: clinical manifestations and diagnostic evaluation. Am Fam Physician. 2000 Sep 1;62(5):1119-27, 1133-4. Erratum in: Am Fam Physician 2002 Feb 1;65(3):386. PMID: 10997535.
Raff H, Sharma ST, Nieman LK. Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia. Compr Physiol. 2014 Apr;4(2):739-69. doi: 10.1002/cphy.c130035. PMID: 24715566; PMCID: PMC4215264.
Bertagna X, Guignat L, Groussin L, Bertherat J. Cushing's disease. Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):607-23. doi: 10.1016/j.beem.2009.06.001. PMID: 19945026.
Nieman LK. Cushing's syndrome: update on signs, symptoms and biochemical screening. Eur J Endocrinol. 2015 Oct;173(4):M33-8. doi: 10.1530/EJE-15-0464. Epub 2015 Jul 8. PMID: 26156970; PMCID: PMC4553096.
Sharma ST, Nieman LK, Feelders RA. Cushing's syndrome: epidemiology and developments in disease management. Clin Epidemiol. 2015 Apr 17;7:281-93. doi: 10.2147/CLEP.S44336. PMID: 25945066; PMCID: PMC4407747.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Dominika Ćwik-Błotnicka, Karolina Nitka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 426
Number of citations: 0